Calves from cows with MAP-positive test results had significantly lower AWWs than did calves from cows with MAP-negative test results, which translated into economic losses for MAP-infected beef herds.
This study compares the perceptions of producers and veterinarians on the economic impacts of Mycobacterium avium subspecies paratuberculosis (MAP) infection in cow-calf herds. Questionnaires were mailed to beef producers through the Designated Johne's Coordinators and to veterinarians belonging to a nationwide professional organization. Important components of losses associated with MAP infected cows were used to estimate total loss per infected cow-year using an iterative approach based on collected survey data. Veterinarians were more likely to perceive a lower calving percentage in MAP infected cows compared to producers (P=0.02). Income lost due to the presence of Johne's disease (JD) in an infected cattle herd was perceived to be higher by veterinarians (P<0.01). Compared to veterinarians without JD certification, seedstock producers were more likely to perceive genetic losses due to culling cows positive for MAP (P<0.01). There were mixed opinions regarding the magnitude of lowered weaning weight in calves from infected cows and perceived differences in risk of other diseases
BackgroundEfforts to educate producers and veterinarians in the United States regarding the management, prevention and control of Mycobacterium avium subspecies paratuberculosis (MAP) infection have increased over recent years. While nationwide awareness about MAP infection is improving, current level of awareness among beef producers and veterinarians is largely unknown. This study compares the perceptions of beef producers and veterinarians on the burden of MAP infection in cow-calf herds and on measures to control new infections. Questionnaires were mailed to 989 US beef producers through state Designated Johne’s Coordinators and to 1080 bovine veterinarians belonging to a US nationwide professional association.ResultsTwenty-two percent (34/155) of producers reported having infected animals in their herds. The mean (minimum, median, maximum) prevalence reported by producers was 0.8% (0, 0, 10). Twenty-seven percent (27/100) of producers had at least one clinical animal during the previous year. Compared to the small herds (<50 head), the mean test-positive percentages and estimated prevalences were higher in medium (50–149) and highest in large (≥150) herds. Seedstock herds had a lower prevalence and these producers were more likely to enroll in Johne’s disease (JD) control programs and test their herds. Veterinarians reported a mean overall animal level prevalence in their client herds of 5% (0, 2, 60). Similarly, 26% (0, 10, 100) of client herds had at least one infected animal. Mean percentage of infected cows within infected herds was 9% (0.01, 5, 80). Producers generally performed activities to control MAP transmission more frequently than perceived by veterinarians. Compared to veterinarians’ opinions, producers were less likely to cull cows with signs consistent with JD (P < 0.01), but more likely to test purchased additions (P < 0.01). Testing recommendations by veterinarians (n = 277) for beef cow-calf herds were bacterial culture of feces (3%), PCR (14%), ELISA (35%) and a combination of these tests (47%). Seventy-nine percent of veterinarians recommended a 12-month interval between testing.ConclusionsSeedstock producers who had had JD risk assessments performed on their farms were more supportive of JD control programs and had a correspondingly lower prevalence. It is important to increase educational activities to provide relevant information to veterinarians and producers for better management and control of JD. Educational programs should target larger herds to maximize the impact.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.